Abstract
Introduction
A growing number of studies have found evidence that anxiety and depressive disorders are associated with atypical amygdala hyperactivation, which decreases with effective treatment. Interest has emerged in this phenomenon as a possible biological marker for individuals who are likely to benefit from tailored treatment approaches.
Objective
The present study was designed to examine relationships between pretreatment amygdala activity and treatment response in a sample of anxious children and adolescents.
Materials and methods
Participants, who were diagnosed predominantly with generalized anxiety disorder (GAD), underwent functional magnetic resonance imaging (fMRI) scanning before treatment with fluoxetine or cognitive behavioral therapy (CBT).
Results
Results indicated significant negative associations between degree of left amygdala activation and measures of posttreatment symptom improvement in the group, as a whole.
Discussion
Taken together with research on associations between adult amygdala activation and treatment response, these findings suggest that patients whose pretreatment amygdala activity is the strongest may be particularly likely to respond well to such widely used treatments as selective serotonin reuptake inhibitor (SSRI) medications and CBT.
Similar content being viewed by others
References
Armony JL, Corbo V, Clement M-H, Brunet A (2005) Amygdala response in patients with acute PTSD to masked and unmasked emotional facial expressions. Am J Psychiatr 162(10):1961–1963
Beidel DC, Turner SM, Morris TL (2000) Behavioral treatment of childhood social phobia. J Consult Clin Psychol 68(6):1072–1080
Brent DA, Kolko DJ, Birmaher B, Baugher MM, Bridge J, Roth C, Holder D (1998) Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. J Am Acad Child Adolesc Psych 37(9):906–914
Bruder GE, Otto MW, McGrath PJ, Stewart JW, Fava M, Rosenbaum JF, Quitkin FM (1996) Dichotic listening before and after fluoxetine treatment for major depression: relations of laterality to therapeutic response. Neuropsychopharmacology 15(2):171–179
Bruder GE, Stewart JW, Tenke CE, McGrath PJ, Leite P, Bhattacharya N, Quitkin FM (2001) Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant. Biol Psychiatry 49(5):416–425
Bruder GE, Stewart JW, McGrath PJ, Deliyannides D, Quitkin FM (2004) Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men. Neuropsychopharmacology 29(9):1752–1761
Del-Ben CM, Deakin JF, McKie S, Delvai NA, Williams SR, Elliott R, Dolan M, Anderson IM (2005) The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 30(9):1724–1734
Ekman P, Friesen WV (1976) Pictures of facial affect. Consulting Psychologists Press, Palo Alto, CA
Etkin A, Klemenhagen KC, Dudman JT, Rogan MT, Hen R, Kandel ER, Hirsch J (2004) Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron 44(6):1043–1055
Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J, Andrew CM, Pich EM, Williams PM, Reed LJ, Mitterschiffthaler MT, Suckling J, Bullmore ET (2004) Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61(9):877–889
Furmark T, Tillfors M, Marteinsdottir I, Fischer H, Pissiota A, Langstrom B, Fredrikson M (2002) Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 59(5):425–433
Furmark T, Appel L, Michelgard A, Wahlstedt K, Ahs F, Zancan S, Jacobsson E, Flyckt K, Grohp M, Bergstrom M (2005) Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biol Psychiatry 58(2):132–142
Gur RC, Ragland JD, Moberg PJ, Turner TH, Bilker WB, Kohler C, Siegel SJ, Gur RE (2001) Computerized neurocognitive scanning: I. methodology and validation in healthy people. Neuropsychopharmacology 25:766–776
Hammad TA, Laughren T, Racoosin J (2006) Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 63(3):332–339
Harmer CJ, E. MC, Reid CB, Cowen PJ, Goodwin GM (2006) Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry Epub ahead of print
Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL (2004) Efficacy and safety of antidepressants for children and adolescents. BMJ 328(7444):879–883
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for affective disorders and schizophrenia for school-age children-present lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36(7):980–988
Kendall PC, Hedtke KA (2006) Cognitive-behavioral therapy for anxious children: therapist manual, 3rd edn. Workbook Publishing, Inc, Ardmore, PA
Killgore WDS, Yurgelun-Todd DA (2005) Social anxiety predicts amygdala activation in adolescents viewing fearful faces. Neuroreport 16(15):1671–1675
Kilts CD, Kelsey JE, Knight B, Ely TD, Bowman FD, Gross RE, Selvig A, Gordon A, Newport DJ, Nemeroff CB (2006) The neural correlates of social anxiety disorder and response to pharmacotherapy. Neuropsychopharmacology (in press)
McClure EB, Monk CS, Nelson EE, Zarahn E, Leibenluft E, Bilder RM, Charney DS, Ernst M, Pine DS (2004) A developmental examination of gender differences in brain engagement during evaluation of threat. Biol Psychiatry 55(11):1047–1055
McClure EB, Monk CS, Nelson EE, Parrish JM, Adler A, Blair RJR, Fromm SJ, Charney DS, Leibenluft E, Ernst M, Pine DS: Abnormal attention modulation of fear circuit activation in pediatric Generalized Anxiety Disorder. Arch Gen Psychiatry (in press)
Monk CS, McClure EB, Nelson EE, Zarahn E, Bilder RM, Leibenluft E, Charney DS, Ernst M, Pine DS (2003) Adolescent immaturity in attention-related brain engagement to emotional facial expressions. Neuroimage 20(1):420–428
Monk CS, Nelson EE, McClure EB, Mogg K, Bradley BP, Leibenluft E, Blair RJR, Chen G, Charney DS, Ernst M, Pine DS (2006) Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder. Am J Psychiatr 163(6):1091–1097
Pessoa L, McKenna M, Gutierrez E, Ungerleider LG (2002) Neural processing of emotional faces requires attention. PNAS 99(17):11458–11463
Pessoa L, Padmala S, Morland T (2005) Fate of unattended fearful faces in the amygdala is determined by both attentional resources and cognitive modulation. NeuroImage 28(1):249–255
Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR (2005) 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8(6):828–834
Phan KL, Fitzgerald DA, Nathan PJ, Tancer ME (2006) Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry 59(5):424–429
Phelps EA, LeDoux JE (2005) Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48(2):175–187
Rauch SL, Whalen PJ, Shin LM, McInerney SC, Macklin ML, Lasko NB, Orr SP, Pitman RK (2000) Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 47(9):769–776
Renaud J, Brent DA, Baugher M, Birmaher B, Kolko DJ, Bridge J (1998) Rapid response to psychosocial treatment for adolescent depression: a two-year follow-up. J Am Acad Child Adolesc Psych 37(11):1184–1190
Rich BA, Vinton DT, Roberson-Nay R, Hommer RE, Berghorst LH, McClure EB, Fromm SJ, Pine DS, Leibenluft E (2006) Limbic hyperactivation during processing of neutral facial expressions in children with bipolar disorder. Proc Natl Acad Sci USA 103(23):8900–8905
Roberson-Nay R, McClure EB, Monk CS, Nelson EE, Guyer AE, Fromm SJ, Charney DS, Leibenluft E, Blair J, Ernst M, Pine DS (2006) Increased amygdala activity during successful memory encoding in adolescent major depressive disorder: an fMRI study. Biol Psychiatry in press; Epub ahead of press
RUPP (2001) Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. N Engl J Med 344(17):1279–1285
Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA (2001) Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 50:651–658
Siegle GJ, Carter CS, Thase ME (2006) Use of fMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatr 163(4):735–738
Stein MB, Goldin PR, Sareen J, Zorrilla LTE, Brown GG (2002) Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 59(11):1027–1034
Straube T, Mentzel H-J, Miltner WHR (2006) Neural mechanisms of automatic and direct processing of phobogenic stimuli in specific phobia. Biol Psychiatry 59(2):162–170
Szeszko PR, Robinson D, Alvir JM, Bilder RM, Lencz T, Ashtari M, Wu H, Bogerts B (1999) Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry 56(10):913–919
Thomas KM, Drevets WC, Dahl RE, Ryan ND, Birmaher B, Eccard CH, Axelson D, Whalen PJ, Casey BJ (2001) Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry 58(11):1057–1063
Tottenham N, Borscheid A, Ellertsen K, Marcus DJ, Nelson CA (2002) Categorization of facial expressions in children and adults: establishing a larger stimulus set, Poster presented at the Cognitive Neuroscience Society Annual Meeting. San Francisco
Treatment for Adolescents With Depression Study T (2004) Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292(7):807–820
Walkup JT, Labellarte MJ, Riddle MA, Pine D, Greenhill L, Klein RG, Davies M, Sweeney M, Fu C, Abikoff H, Hack S, Klee B, McCracken J, Bergman L, Piacentini J, March J, Compton S, Robinson J, O’Hara T, Baker S, Vitiello B, Ritz L, Roper M (2003) Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psych 42(1):13–21
Wechsler D (1999) Wechsler abbreviated scale of intelligence. San Antonio, Texas, The Psychological Corporation
Vasa RA, Carlino AR, Pine DS (2006) Pharmacotherapy of depressed children and adolescents: current issues and potential directions. Biol Psychiatry 59(11):1021–1028
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McClure, E.B., Adler, A., Monk, C.S. et al. fMRI predictors of treatment outcome in pediatric anxiety disorders. Psychopharmacology 191, 97–105 (2007). https://doi.org/10.1007/s00213-006-0542-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-006-0542-9